Article | August 18, 2022

3 Biopharma Contract Manufacturing Trends You Must Know

Source: MasterControl, Inc.

By James Jardine

Cell and Gene pharma manufacturing bioprocess GettyImages-1166528646

There's never been more buzz around the biopharma industry or more money being invested in it. The frenzy is being fueled by an ever-expanding array of new modalities like antibody-drug conjugates, mRNA, and other specialized innovations. Contract manufacturing is the engine driving biopharma's enormous growth, playing perhaps a more critical role than in any other sector of the pharmaceutical industry. Three biopharma contract manufacturing trends in particular are indicators of exciting industry developments, but they also reveal areas that are ripe for change.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online